Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Timing of oral contraceptive use and the risk of breast cancer in BRCA1 mutation carriers.

Breast cancer research and treatment - 1 Feb 2014

Kotsopoulos Joanne, Lubinski Jan, Moller Pal, Lynch Henry T, Singer Christian F, Eng Charis, Neuhausen Susan L, Karlan Beth, Kim-Sing Charmaine, Huzarski Tomasz, Gronwald Jacek, McCuaig Jeanna, Senter Leigha, Tung Nadine, Ghadirian Parviz, Eisen Andrea, Gilchrist Dawna, Blum Joanne L, Zakalik Dana, Pal Tuya, Sun Ping, Narod Steven A

Abstract excerpt

It is not clear if early oral contraceptive use increases the risk of breast cancer among young women with a breast cancer susceptibility gene 1 (BRCA1) mutation. Given the benefit of oral contraceptives for the prevention of ovarian cancer, estimating age-specific risk ratios for oral contraceptive use and breast cancer is important. We conducted a case-control study of 2,492 matched pairs of women with a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Age Factors
Share to BRCA1 Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Breast Neoplasms

Share to Case-Control Studies

Share to Contraceptives, Oral

Share to Genetic Association Studies

Share to Heterozygote

Share to Risk Factors

Source

Identifiers

PMID: 24458845
DOI: 10.1007/s10549-013-2823-4

Genes

BRCA1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Timing of oral contraceptive use and the risk of breast cancer in BRCA1 mutation carriers.PMID 24458845Read ↗

Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

BRCA1 and BRCA2 mutation carriers, oral contraceptive use, and breast cancer before age 50.Semantic proximity Read ↗

Impact of teenage oral contraceptive use in a population-based series of early-onset breast cancer cases who have undergone BRCA mutation testing.Semantic proximity Read ↗

Oral contraceptives and breast cancer risk in the international BRCA1/2 carrier cohort study: a report from EMBRACE, GENEPSO, GEO-HEBON, and the IBCCS Collaborating Group.Semantic proximity Read ↗

Hormonal Contraception and Breast Cancer Risk for Carriers of Germline Mutations in BRCA1 and BRCA2.Semantic proximity Read ↗

Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study.Semantic proximity Read ↗

Use of oral contraceptives in BRCA mutation carriers and risk for ovarian and breast cancer: a systematic review.Semantic proximity Read ↗

Oral contraceptive use and breast or ovarian cancer risk in BRCA1/2 carriers: a meta-analysis.Semantic proximity Read ↗

Oral contraceptives and risk of breast cancer and ovarian cancer in women with a BRCA1 or BRCA2 mutation: a meta-analysis of observational studies.Semantic proximity Read ↗

Oral contraceptive use and BRCA penetrance: a case-only study.Semantic proximity Read ↗

The role of oral contraception use in the occurrence of breast cancer. A retrospective study of 405 patients.Semantic proximity Read ↗

Modifying effect of reproductive risk factors on the age at onset of breast cancer for German BRCA1 mutation carriers.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.